Cancer Early Detection Market

The 2 components of early detection of cancer are early diagnosis (or downstaging) and screening. Early diagnosis focuses on detecting symptomatic patients as early as possible, while screening consists of testing healthy individuals to identify those having cancers before any symptoms appear.
Cancer Early Detection Market contains market size and forecasts of Cancer Early Detection in global, including the following market information:
Global Cancer Early Detection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Early Detection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Early Detection companies in 2021 (%)
The global Cancer Early Detection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Colorectal Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Early Detection include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Early Detection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Early Detection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Early Detection Market Segment Percentages, by Type, 2021 (%)
Colorectal Cancer
Liver Cancer
Lung Cancer
Other
Global Cancer Early Detection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Early Detection Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Center
Other
Global Cancer Early Detection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Early Detection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Early Detection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Early Detection revenues share in global market, 2021 (%)
Key companies Cancer Early Detection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Early Detection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Exact Sciences
Grail
Genetron Health
New Horizon Health
Burning Rock
Berry Oncology
Shanghai Kunyuan Biotechnology
Oncognostic
Epigenomics
Abbott
Qiagen
iStat Biomedical